Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer

BACKGROUND: Preoperative radiochemotherapy (RCT) with 5-FU or capecitabine is the standard of care for patients with locally advanced rectal cancer (LARC). Preoperative RCT achieves pathological complete response rates (pCR) of 10-15%. We conducted a single arm phase II study to investigate the feas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dellas, Kathrin, Höhler, Thomas, Reese, Thomas, Würschmidt, Florian, Engel, Erik, Rödel, Claus, Wagner, Wolfgang, Richter, Michael, Arnold, Dirk, Dunst, Jürgen
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3679876/
https://ncbi.nlm.nih.gov/pubmed/23587311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-8-90
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados